---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021100"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2025-07-28T23:59:59+00:00"
generated_at: "2026-05-18T00:24:37.264475+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ZyVersa Therapeutics common stock to trade on OTCQB from July 28

## Summary
- OTCQB approval received on July 25, 2025; trading commences July 28 under ticker ZVSA.
- Move to OTCQB indicates likely delisting from a senior exchange (e.g., Nasdaq).
- No financial terms disclosed; company remains an SEC filer.

## SEC filing metadata
- accession: 0001641172-25-021100
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2025-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000164117225021100/0001641172-25-021100-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000164117225021100/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021100
- JSON: https://secwatch.observer/filing/0001641172-25-021100.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021100.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.